CTOs on the Move

Excision BioTherapeutics

www.excision.bio

 
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.excision.bio
  • 988 Market Street
    San Francisco, CA USA 94102
  • Phone: 404.229.1162

Executives

Name Title Contact Details
Franz Gerner
Chief Technology Officer Profile

Funding

Excision BioTherapeutics raised $60M on 02/17/2021

Similar Companies

Alveo Technologies

At Alveo we understand the importance of access to cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases. With an initial focus on acute respiratory infections including COVID-19, Flu A/B and RSV, Alveo`s agile and dynamic molecular diagnostic platform, be.well™, can be adapted to detect a wide range of diseases, bacteria, and other pathogens that threaten public health, across all modalities. We believe increased access to real-time test results will transform the way individuals, healthcare providers and public health professionals identify and manage infectious diseases. With be.well™, we will Know Sooner, Act Faster™.

BridgeBio

We are a collection of individuals focused on discovering and developing drugs for patients with grievous genetic diseases.

Ribomed Biotechnologies

Ribomed Biotechnologies, Inc. is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dow Pharmaceutical Sciences

Dow Pharmaceutical Sciences is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RTD Company

RTD Company is a Andover, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.